Tetrahydro-1H-pyrrolizine-7a(5H)-acetic acid hydrochloride

We are Tetrahydro-1H-pyrrolizine-7a(5H)-acetic acid hydrochloride CAS:124655-63-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Tetrahydro-1H-pyrrolizine-7a(5H)-acetic acid hydrochloride
CAS.NO:   124655-63-6
Synonyms:
PYRROLIZIDINE-7-ACETIC ACID
Pyrrolizidine-9-hydrochloride

Molecular Formula: C9H16ClNO2
Molecular Weight:  205.68200

Physical and Chemical Properties:
Density: /
Boiling point: /
Melting point: /
Flash point: /
Refractive index: /

Specification:
Appearance: White Powder
Purity: >98％
Residue on ignition:0.2% max

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Storage:2°C-8°C.Stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Application:Intermediates of Benzamide CAS:88069-67-4.

Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.459868-73-6 The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.4-(Methylsulfonyl)phenylacetic acid CAS:90536-66-6 In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.ciclohexano-1,3-diona CAS:504-02-9 Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.Retrogenix holds two Queen’s Awards for Enterprise, the UK’s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA.